Vertex Pharmaceuticals
Vertex Pharmaceuticals orporated is an American biotechnology company headquartered in Boston, Massachusetts, United States. Founded in 1989, it develops transformative medicines for serious diseases. Vertex's main segments lude Cystic Fibrosis (TRIKAFTA, 80% of revenue), Non-CF (pain, gene therapy, 15%), and Vertex Ventures (5%). Vertex operates in 100+ countries with 5,000 employees. Its supply chain involves API suppliers, with TPRM per the 2024 Annual Report emphasizing FDA, ESG, and supply chain audits for ethical sourcing. The company invests in cell/gene therapies. In 2024, Vertex reported revenues of $11.02 billion, up 12% from 2023, with Q4 at $2.91 billion and net ome of $3.6 billion.
Vertex Pharmaceuticals Overview
- Company: Vertex Pharmaceuticals
- Industry: Pharmaceuticals
- Employees: 1,001-5,000
- Location: 50 Northern Ave, Boston, MA 02210, USA
- Founded: 1989
Vertex Pharmaceuticals Certifications and Compliance
Through Panorays' Attack Surface Assessments, you can view all identified published certifications, providing a clearer and more accurate understanding of your compliance status
Vertex Pharmaceuticals Cyber Related News
Access business-specific cyber news from diverse sources, all categorized and consolidated in one place, ensuring clear visibility into cyber events and incidents relevant to your organization.
#2
Articles Found
| Article | Publish date | Source | Tags |
|---|---|---|---|
| UK Authorizes World-First Gene Therapy... | Nov 17, 2023 | Data Breaches | |
| Gene Therapy Approvals Gain Steam... | Nov 7, 2023 | Data Breaches |
Vertex Pharmaceuticals External Attack Surface Geolocation Map
Gain detailed insights into the location of your assets through our comprehensive external assessments.
Vertex Pharmaceuticals Supply Chain Discovery
Supply Chain Discovery identifies Nth-party connections to your company, maps their relationships, and continuously monitors them for cyber threats. The following graph segments detected third parties according to their Cyber Posture Rating.
Vertex Pharmaceuticals Cyber Posture Rating
Vertex Pharmaceuticals security rating reflects the analysis of its external attack surface. A higher rating indicates a stronger security posture. Begin a free trial to receive a comprehensive risk assessment for Vertex Pharmaceuticals.
Is this your company? Claim your security score now.
NA
Vertex Pharmaceuticals Category Breakdown
Human
Employee
NA
Security Team
NA
Social Posture
NA
Dynamics
NA
Application
Techs
NA
Application Security
NA
Domain Attacks
NA
Exposed Services
NA
IT
DNS
NA
Mail Server
NA
Asset Reputation
NA
Web Server
NA
TLS
NA
Cloud
NA
Endpoint
NA
Panorays Named a Leader in The Forrester Wave™ in Cybersecurity Risk Ratings Platforms, Q2 2024
“Panorays best fits enterprise TPRM programs”
Is your organization secure?
Discover critical risks and vulnerabilities in your supply chain with our comprehensive report.